INTRODUCTION {#S1}
============

Although genetic mutations that result in the development of familial Parkinson's disease (PD) have been identified, these account for a minority of disease cases. The majority of cases are sporadic in nature and likely involve the contribution of various environmental exposures over the course of the lifespan ([@R55]). A better understanding of the mechanisms involved in the contribution of these factors to neuropathology is a vital missing piece of the puzzle that will help unravel the underlying causes of idiopathic disease. Exposure to the herbicide paraquat (PQ) is strongly associated with increased lifetime risk for the development of sporadic PD. Its systemic administration in mice results in several hallmark neuropathological features of the disorder. However, therapies based on the agent's presumed mechanisms of action have yet to yield effective disease therapies ([@R27]; [@R55]). Preventive and therapeutic treatments for idiopathic PD may require uncovering of disease mechanisms and targets distinct from those identified to date.

We report the contribution of a factor thought to contribute to aging in many tissues: cellular senescence ([@R12]; [@R14], [@R15]; [@R43]). Cellular senescence is an anticancer mechanism occurring in cells capable of division, and it results in irreversible arrest of cell proliferation in response to stress that puts cells at risk for malignant transformation ([@R12]; [@R41]). Senescent cells express a senescence-associated secretory phenotype (SASP)---the robust secretion of numerous inflammatory cytokines, chemokines, growth factors, and proteases ([@R16]). Senescent cells accumulate with age in many human and mouse tissues. There, presumably by virtue of the SASP, they have been shown to contribute to the age-related loss of tissue structure and function ([@R2]; [@R12]; [@R20]; [@R34]; [@R50]). Cellular senescence may be an example of evolutionary antagonistic pleiotropy---protecting organisms from cancer early in life but driving aging phenotypes at advanced age.

Although senescent cells have been demonstrated to contribute to age-related pathologies outside the brain, evidence to date for their contribution to age-related neurodegenerative diseases is only correlative ([@R5]; [@R15]; [@R33]; [@R43]; [@R49]). Here, we report that postmortem tissue from sporadic PD patients displays increased expression of senescent markers, particularly within astrocytes. PQ is also able to induce senescence in cultured human astrocytes and *in vivo*. Significantly, inducible depletion of *in vivo* senescence reduces the development of neurodegenerative phenotypes associated with systemic PQ exposure, demonstrating that senescent cells contribute to neurodegeneration in an *in vivo* neurodegenerative disease model. Our data suggest that strategies aimed at eliminating senescent cells hold promise as potential therapies to mitigate the development of sporadic PD, for which environmental stress is a major contributing factor.

RESULTS {#S2}
=======

Senescent Astrocytes and SASP Factors Are Elevated in Parkinsonian Substantia Nigra Pars Compacta {#S3}
-------------------------------------------------------------------------------------------------

Astrocytes expressing senescence markers increase in human brain tissue during normal aging ([@R25]) and further in affected brain regions of individuals with Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS) ([@R5]; [@R49]), prompting us to ask whether senescent astrocytes are also present in PD ([Figures 1A and 1B](#F1){ref-type="fig"}). Compared to control tissues, Parkinsonian SNpc tissues displayed elevated expression of the senescence marker p16^INK4a^, and several SASP factors included the protease MMP-3 and the pro-inflammatory cytokines interleukin-6 (IL-6), IL-1α, and IL-8 ([Figure 1A](#F1){ref-type="fig"}). Elevated p16^INK4a^ and MMP-3 expression has also been reported in cortical tissue from AD patients ([@R5]).

We next determined whether SNpc astrocytes in particular display evidence of cellular senescence in PD tissues. A reduced nuclear level of lamin B1, detectable by immunostaining in intact tissue, is an established senescence-associated marker ([@R21]). Astrocytes (GFAP^+^ cells) were found to be lamin B1 deficient in PD SNpc tissues while no significant difference was detected in PD versus aged-matched control tissues in non-astrocytic (GFAP^−^) neighboring cells ([Figures 1B](#F1){ref-type="fig"} and [S1](#SD2){ref-type="supplementary-material"}). These findings suggest the elevated presence of senescence in affected PD tissues and that astrocytes may preferentially undergo senescence in diseased brain tissues.

PQ Induces Senescence and an SASP in Human iPSC-Derived Astrocytes {#S4}
------------------------------------------------------------------

We next assessed the ability of human astrocytes derived from induced pluripotent stem cells (iPSCs) to undergo senescence in response to PQ, an environmental insult significantly associated with PD ([@R39]). In adult mice, chronic, low-dose systemic exposure to PQ recapitulates several important hallmarks of the disease, including selective loss of dopaminergic (DAergic) SNpc neurons and reduced motor function ([@R31]; [@R39]; [@R48]). Cultured human astrocytes exposed to PQ ceased proliferation based on decreased percentage of bromo-deoxyuridine (BrdU)-labeled cells ([Figure 2A](#F2){ref-type="fig"}). They also displayed several additional hallmarks of senescence, including increased senescence-associated β-galactosidase (SA-β-gal) activity ([@R20]) ([Figure 2B](#F2){ref-type="fig"}), increased levels of p16^INK4a^ ([@R4]) mRNA and protein ([Figures 2C and 2D](#F2){ref-type="fig"}), and increased numbers of 53BP1 foci, the latter indicative of DNA-damage signaling, which is a potent stimulator of the SASP ([@R4])([Figure 2E](#F2){ref-type="fig"}). Consistent with development of an SASP, PQ also induced robust secretion of the pro-inflammatory cytokine IL-6 ([Figure 2F](#F2){ref-type="fig"}), a prominent component of the SASP ([@R16]).

Given that genotoxic stress induced by ionizing radiation (IR) initiates senescence with well-documented effects on mitosis and nuclear size ([@R40]), we verified that compared to IR, PQ caused a similar decrease in the percentage of Ki67^+^ cells ([Figure 3A](#F3){ref-type="fig"}) and an increase in the mean size of astrocyte nuclei ([Figure. 3B](#F3){ref-type="fig"}). Human fibroblasts cultured with PQ for 24 hr also displayed these phenotypes as well as decreased Lamin B1 levels and increased SA-β-gal activity ([Figures 3A--3D](#F3){ref-type="fig"}). These data indicate that PQ is capable of inducing senescence in human astrocytes as well as human fibroblasts ([@R24]). However, astrocytes were more sensitive than fibroblasts to PQ-induced senescence based on SA-β-gal activity. Interestingly, a concentration of PQ that induced fibroblast senescence (\>500 μM PQ) was lethal to astrocytes ([Figure 3D](#F3){ref-type="fig"}).

Epidemiological data suggest that, although the risk for developing PD is significant following a short-term (\<8 day) environmental exposure to PQ, PD is even more significantly linked with chronic/low-dose PQ exposure ([@R48]). We asked whether lower concentrations of PQ for a longer duration could induce senescence in human astrocytes. Cells exposed for 48 hr to 10 μM PQ showed a significant increase in SA-β-gal^+^ cells, and a 48-hr exposure to 50 μM PQ was nearly as effective as a 24- hr exposure to 100 μM PQ ([Figure 4A](#F4){ref-type="fig"}). All exposures and concentrations reduced cell numbers compared to vehicle-treated cells consistent with proliferative arrest ([Figure 4B](#F4){ref-type="fig"}). Lower more sustained PQ doses increased the percentage of senescent astrocytes to a similar or greater extent than exposure to H~2~0~2~ (150 mM for 2 hr) or the proteasomal inhibitor MG132 (50 nM for 48 hr) ([Figure 4A](#F4){ref-type="fig"}), which are stress conditions reported to induce senescence of cultured human astrocytes ([@R6]).

Soluble Factors Secreted by Senescent Human Astrocytes Compromise the Function of Neurons and Neural Progenitor Cells {#S5}
---------------------------------------------------------------------------------------------------------------------

Senescent cells can exert powerful paracrine effects on tissue microenvironments ([@R17]); SASP factors have been shown to disrupt tissue structure and function ([@R10]). We asked whether PQ-induced senescent astrocytes could drive PD-related neuropathologies associated with the neurotoxin, including DAergic neuronal cell death ([@R7]) and reduced neural progenitor cell (NPC) proliferation and migration ([@R30]). We cultured human DAergic neurons and NPCs in the presence of conditioned media (CM) from human astrocytes. CM from PQ-induced senescent astrocytes, but not non-senescent (vehicle-treated) astrocytes, significantly reduced the viability of DAergic neurons ([Figure 5A](#F5){ref-type="fig"}). Similarly, CM from senescent astrocytes suppressed both NPC proliferation ([Figure 5B](#F5){ref-type="fig"}) and migration ([Figure 5C](#F5){ref-type="fig"}).

IL-6 is a prominent SASP factor, and elevated serum levels are associated with increased PD risk ([@R44]). Treating cultured DAergic neurons with recombinant IL-6 at the concentration found in the CM of PQ-treated astrocytes (1.5 μM) showed a trend toward reducing DAergic cell viability, but the effect was not statistically significant ([Figure S2](#SD2){ref-type="supplementary-material"}). This finding suggests that although IL-6 may contribute to neurotoxic SASP effects, additional factors are likely needed to mediate the detrimental impact on DAergic viability.

Depleting Senescent Cells Abrogates PQ-Induced Neuropathology {#S6}
-------------------------------------------------------------

To test whether PQ-induced senescence contributes to neuropathologies *in vivo*, we used a mouse model that allows selective depletion of senescent cells ([@R19]). These mice (p16-3MR) use the promoter for the senescence marker p16INK4a to drive expression of a modified herpes simplex virus thymidine kinase (HSV-TK), which converts the pro-drug ganci-clovir (GCV) into a DNA chain terminator, causing cells to apoptose ([@R26]). GCV eliminates 70%--80% of senescent cells in p16-3MR mice without discernible off-target or bystander effects ([@R19]).

We subjected p16-3MR mice to a systemic PQ regimen shown to result in several neuropathological features of PD ([@R31]; [@R46]). PQ increased nigrostriatal expression of p16INK4a and IL-6 ([Figure 6A](#F6){ref-type="fig"}). As was the case for human astrocytes, PQ-treated p16-3MR astrocytes display increased SA-β-gal activity and were more sensitive to PQ-induced toxicity. Similar to astrocytes in human PD tissues, astrocytes from PQ-treated mice also displayed significant loss of nuclear lamin B1 and HMGB1 (high mobility group box 1), the latter necessary for SASP initiation ([Figures 6B and 6C](#F6){ref-type="fig"}) ([@R18]). Similar to our findings in the human PD SNpc, PQ did not significantly reduce nuclear lamin B1 in GFAP^−^ cells ([Figure 6D](#F6){ref-type="fig"}). Significantly, all senescent phenotypes in the SNpc were abrogated in mice in which senescent cells were eliminated by systemic GCV administration ([Figures 6A--6D](#F6){ref-type="fig"}). We failed to detect a decline in the proliferation marker Ki67 in astrocytes in PQ-treated mice ([Figure S3](#SD2){ref-type="supplementary-material"}). However, Ki67 staining in astroglia in saline-treated animals was within the range of post-mitotic neurons and less than half the levels found in Ki67+ cells within the inner granule cell layer of the dentate gyrus, which are presumed to be actively dividing granule cell progenitors ([@R35]).

Human PD neuropathology is characterized by the preferential loss of DAergic neurons in the SNpc, resulting in impairment of locomotor function ([@R23]). These phenotypes are recapitulated in the systemic PQ murine model. In the mouse SNpc, PQ caused a significant decline in a marker of DAergic neurons, tyrosine hydroxylase (TH); co-administration of GCV with PQ prevented this decline ([Figure 7A](#F7){ref-type="fig"}). Systemic PQ administration is known to repress adult neurogenesis, but co-GCV administration abrogated this effect ([Figure 7B](#F7){ref-type="fig"}) ([@R30]). Finally, rearing behavior, a measure of motor neuron function more sensitive to DAergic cell loss than other motor tests ([@R54]), was significantly curbed in mice treated with PQ alone but normal in mice co-treated with GCV ([Figure 7C](#F7){ref-type="fig"}). Taken together, these results suggest that senescent cell depletion abrogates PQ-mediated neuropathology and motor deficits.

DISCUSSION {#S7}
==========

Late-onset idiopathic PD is thought to result from the combined effects of genetic risk factors, aging, and environmental exposure. Data from several laboratories suggest that humans and animals exposed to certain chemicals can develop neuropathological phenotypes associated with PD ([@R13]; [@R32]; [@R38]). One of the best studied of these is PQ. A meta-analysis of \>100 epidemiological studies concluded that of several specific pesticides and chemical classes evaluated, only PQ was significantly associated with PD. Moreover, as this study points out, the epidemiologic data are backed by numerous animal studies demonstrating that PQ selectively depletes SNpc DAergic neurons and reduces motor function in adult mice, which are important hallmarks of human PD ([@R39]).

PQ is a free radical generator that causes oxidative stress ([@R11]), which has been demonstrated to induce cellular senescence in replication-competent cell types ([@R12]). PQ also results in compromised mitochondrial function, which has recently been tied to senescence induction in human fibroblasts ([@R53]). One mechanism by which PQ may contribute to PD is by inducing cellular senescence within the brain ([@R14]). Indeed, PQ induced senescence more readily in cultured human and murine astrocytes than in human fibroblasts, and their sensitivity was found to track with baseline SA-β-gal activity. Our studies suggest that PQ, like other inducers of senescence ([@R36]), has a bandwidth of concentrations that induce senescence; above an upper limit, cells die. This finding raises the possibility that astrocytes are particularly prone to undergo senescence in response to chronic low-dose exposure to PQ that is associated with late-onset idiopathic PD. Indeed, administration of PQ to mice appears to preferentially increase senescent markers in astrocytes. Importantly, senescence markers were also elevated in astrocytes in SNpc tissues from autopsied PD brain samples, suggesting that the proclivity for astrocytes to undergo senescence may have physiological disease relevance. To our knowledge, this is the first report of elevated senescent markers in the PD brain.

While our data suggest that senescence occurs preferentially within astrocytes, this does not rule out senescence induction of other brain cell types. While neurons are post-mitotic and therefore unlikely to undergo traditional senescence induction, senescence has reported in other non-astrocytic cell types. For example, in response to repeated lipopolysaccharide administration, microglial BV2 cells display growth arrest, enhanced SA-β-gal activity, and heterochromatic foci ([@R56]). Based on our own findings that PQ can mediate senescence in disparate cell types (astrocytes and fibroblasts), we anticipate that at some concentrations PQ may induce senescence of other replicative brain cell types.

It is theoretically possible that senescence induction in peripheral tissues could contribute to PQ-mediated brain pathologies, but this seems unlikely, as the chronic, low-dose PQ regimen utilized in our studies is known to result in receptor-mediated uptake and immune response in the brain ([@R31]) without activating peripheral immune cells or disrupting blood-brain barrier integrity ([@R51]; [@R52]).

How might senescent astrocytes contribute to PD neuropathology? Mature astrocytes rarely divide in the adult brain ([@R22]; [@R47]), consistent with our inability to detect Ki67^+^ astrocytes in the adult mouse brain; however, astrocytes do divide in response to certain injury ([@R3]) and disease states ([@R8]; [@R9]). The inability of senescent astrocytes to proliferate may exacerbate neuropathology when proliferation is an appropriate response to injury or disease. Astrocytes provide structural, metabolic, and trophic support to neurons ([@R1]). When astrocytes adopt pro-inflammatory phenotypes, they can compromise neuronal function and contribute to age-related neurodegeneration and decrements in brain function *in vivo* ([@R42]; [@R43]). Factors secreted by senescent astrocytes had detrimental effects on both cultured human DAergic neurons and NPCs. CM from senescent astrocytes was supplemented with growth factors; therefore, trophic factor depletion seems an unlikely explanation. Secretion of IL-6 by cultured senescent human astrocytes was recently reported to decrease the viability of co-cultured motor neurons ([@R49]). We observed a similar increase in IL-6 secretion following PQ treatment in culture or *in vivo*, but IL-6 alone was not sufficient to induce significant degeneration of cultured DAergic neurons, suggesting that additional SASP factors may be required.

Why do DAergic SNpc neurons selectively degenerate in response to PQ and in PD? This is a pressing question in the field that our study does not explicitly address. However, we hypothesize that DAergic SNpc neurons may be particularly sensitive to the effects of oxidative stress on neighboring astrocytes, including senescence induction. In agreement with this idea, using an inducible astrocyte-specific oxidative stress mouse model, we previously demonstrated selective degeneration of DAergic SNpc neurons, despite astrocytes in other brain regions experiencing similar levels of oxidative stress ([@R29]).

In conclusion, our data show that astrocytes undergo cellular senescence in response to a well-established environmental stressor linked to PD and, significantly, that PQ-induced senescence contributes to PD-related neuropathology. This finding provide novel links among environmental exposure, cellular senescence, and PD. Further studies are warranted to identify other environmental and endogenous stressors capable of senescence induction in the brain. Our results suggest that senescent cells might be a novel therapeutic target for sporadic PD and other chronic neurodegenerative diseases in which environmental factors are implicated.

EXPERIMENTAL PROCEDURES {#S8}
=======================

PD Tissues and Ethics Statement {#S9}
-------------------------------

Formalin-fixed paraffin-embedded SNpc sections were obtained from the Neurodegenerative Disease Research Brain Bank, University of Pennsylvania (U Penn) Center for Neurodegenerative Disease Research. Samples were from subjects aged 50--92 years at autopsy with previously diagnosed PD. Control samples were from age- and sex-matched subjects without PD. All samples were de-identified and obtained after approval by the U Penn institutional review board (protocol number 180600). A broker de-identified each specimen, no protected health information was made available to the researcher, and specimens were assigned numbers that could not be traced to the donors. There is no link between donor identifiers and the data; therefore, consent for this protocol was waived.

qPCR of Human Tissues and Cells {#S10}
-------------------------------

Total RNA was prepared from human SNpc or human-iPSC-derived cells using TRIzol (Invitrogen) and reverse transcribed using an Applied Biosystems kit (Carlsbad, CA). qRT-PCR was performed using the Universal Probe Library system (Roche, South San Francisco, CA) with the following primers and probes:

1.  *p16^INK4a^*: forward (FW) 5′-gagcagcatggagccttc-3′; RV 5′-cgtaactattcggtg cgttg-3′

2.  *IL-6:* FW 5′-gcccagctatgaactccttct-3′; RV 5′-gaaggcagcaggcaacac-3′

3.  *IL-1α:* FW 5′-ggttgagtttaagccaatcca-3′; RV 5′-tgctgacctaggcttgatga-3′

4.  *IL-8:* FW 5′-agacagcagagcacacaagc-3′; RV 5′-atggttccttccggtggt-3′

5.  *MMP-3:* FW 5′-caaaacatatttctttgtagaggacaa-3′;RV 5′-ttcagctatttgcttgg gaaa-3′.

Immunofluorescence of Human SNpc Tissue {#S11}
---------------------------------------

SNpc sections (6 μM) were rehydrated as follows: 2 × 7 min, xylene; 4 min each; 100%, 95%, 80%, and 70% ETOH; rinsed in dH~2~0; and washed in Tris-buffered saline (TBS), 10 min. Slides were then microwaved in 10 mM citrate buffer (pH 6.0) for 5 min at 40% power, cooled for 20 min, washed 10 min in TBS, and then blocked with 10% normal goat serum (NGS) in TBS + 0.05% Triton X-100 for 1 hr at room temperature. Sections were incubated at 4°C overnight with primary antibodies in blocking buffer (chicken TH: Novus, NB100-1613, 1:200 dilution; lamin B1: Abcam, ab16048, 1:200 dilution). Slides were washed three times in TBS followed by TBS, 0.025% Tween-20, 5% normal goat serum, and fluorescent conjugated antibodies (goat anti-rabbit-488: Life Technologies, A31566, 1:500 dilution; goat-anti chicken 633: Life Technologies, A21103, 1:500 dilution; and GFAP-cy3: Sigma, C9205, 1:2,000 dilution). Slides were washed three times in TBS and mounted with ProLong Gold plus DAPI (Life Technologies, P36934).

Lamin B1 Quantitation in Human SNpc Astrocytes {#S12}
----------------------------------------------

Immunostained sections were imaged with a Zeiss LSM 780 using an EC Plan-Neofluar 40×/1.30 oil Ph3 objective. 10× bright-field microscopy was used to locate GFAP^+^ cells in the vicinity of clustered pigmented neurons. A z stack spanning the cell body was acquired at 1,024 × 1,024 −12 bit at 3× zoom using 1-μm steps. Fluorescence intensity was assessed using ImageJ. The optical section with the greatest green intensity (lamin B1) was identified. In the DAPI channel, the edge of the DAPI signal was outlined (defining the nuclear lamina), and the mean pixel value (MPV) on the green channel (lamin B1) was calculated; this signal was divided by a signal outside all nuclei in order to normalize for background staining and normalized fluorescence intensity averaged across 5 GFAP^+^ cells within a single section. Neighboring GFAP^−^ cells were chosen based on being closest and in the same Z section as the analyzed astrocyte. Significance was calculated using a paired t test pairing age- and sex-matched individuals from PD and control groups (n = 5 PD samples, 5 controls).

Treatment of Human Cultures {#S13}
---------------------------

Human astrocytes derived from iPSCs purchased from XCell Science (Novato CA) grown in astrocyte media were cultured at 37°C, 3% O~2~, and 5% CO~2~ in DMEM supplemented with 10% horse serum, 10% fetal bovine serum (FBS), and penicillin/streptomycin. Cells were seeded at 1 × 10^4^ cells/cm^2^ and cultured to 70%--80% confluence. WI-38 primary human fibroblasts were obtained from the Coriell Cell Repository. Cell culture and irradiation (IR, 10 Gy X-rays) were carried out as described previously ([@R21]). Cells were treated with indicated PQ concentrations for 24 or 48 hr and washed twice with culture media; analyses were performed 7--8 days later.

BrdU Incorporation {#S14}
------------------

Cell proliferation was determined by measuring DNA synthesis using a modified BrdU labeling kit (Roche). Cells were seeded in 4-well chamber slides and incubated with BrdU for 1 hr before washing and fixing with 4% paraformaldehyde. Fixed cells were washed with PBS and BrdU immunofluorescence quantified.

SA-β-gal Assay {#S15}
--------------

SA-β-gal staining was performed as described previously ([@R20]). Cells were plated at 1 × 10^4^ cells/cm^2^ and assessed for SA-β-gal activity 24--48 hr after seeding in a minimum of 400 cells. Positive (blue) cells are expressed as a percentage of total cell number.

Immunofluorescence of Cultured Cells {#S16}
------------------------------------

Cells were fixed with 4% formaldehyde, permeabilized with 0.5% Triton, and blocked with 10% goat or donkey serum before incubating overnight with primary antibody at 4°C. After washing in PBS, cells were incubated with Alexa-conjugated secondary antibodies for 30--45 min at room temperature. Nuclear DNA was stained with DAPI in mounting media (Vectashield). CellProfiler image analysis software was used to score cells. Primary antibodies were anti-p16 (clone JC8: Santa Cruz Biotechnology, sc-56330, 1:200 dilution), anti-53BP1 (clone BP13: EMD Millipore, MAB3802, 1:200 dilution), anti-lamin B1 (Abcam, ab16048, 1:200 dilution), and anti-Ki67 (Abcam, ab15580; 1:200 dilution). For the latter, image data were analyzed using CellProfiler to quantify the number of Ki67^+^ (% Ki67+) DAPI-stained nuclei. The mean pixel area of DAPI-stained nuclei was obtained for each condition (IR and PQ) and normalized to the mean pixel area of nuclei under control conditions (for relative nuclear size).

IL-6 ELISA {#S17}
----------

CM was prepared by washing cells three times in PBS followed by incubation in serum-free DMEM for 24 hr. CM was filtered and stored at −80°C. Cell numbers were determined by counting. ELISAs were performed using the alphaLISA IL-6 Immunoassay Research kit (Perkin Elmer). Data were normalized to cell number and expressed as picograms per 1,000 cells.

Preparation of Primary 3MR Astrocytes {#S18}
-------------------------------------

Primary cortical astrocytes were prepared as described previously ([@R45]). Cortices were dissected from post-natal day 2 mice and dissociated, plated, and cultured for 2 weeks with removal of microglia by orbital shaking prior to conducting experiments. Cells were treated with PQ as indicated and after 24 hr washed twice with culture media. SA-β-gal activity was assessed 8 days after PQ treatment as described above.

Viability of Human DAergic Neurons {#S19}
----------------------------------

Primary human DAergic neurons were obtained from Celprogen (San Pedro, CA) and cultured as instructed by the manufacturer. Cells were maintained in complete medium and subcultured every 24--48 hr on human dopamine neuronal primary cell culture extracellular matrix. Briefly, 1 × 10^4^ cells were plated onto flat-bottomed 96-well plates. CM from astrocytes was concentrated using spin columns with a 10-kDa cutoff and reconstituted in DA-complete media. After 24 hr, cells were exposed to CM astrocytic CM for 72 hr. Cells were treated with 50 μL MTT (3-\[4, 5-dimethylthiazol-2-yl\]-2,5-diphenyl-tertra-zolium bromide) solution (5 mg/mL) for 3 hr at 37°C. 200 μL dimethyl sulfoxide (Sigma, USA) was added to each well and incubated for 30 min at 37°C. Color intensity was quantified at 570 nm. The experiment was run three times in 3 different sets of CM, and each condition was run in quadruplicate.

Derivation of Human NPCs {#S20}
------------------------

Human embryonic stem cell colonies were harvested after collagenase treatment, cultured as embryoid bodies for 8 days in DMEM with 20% FBS, and cultured in neural induction medium (DMEM/F12) N2 supplement (Invitrogen, 25 ng/mL basic fibroblast growth factor \[bFGF\]) for 7 days on plates coated with Geltrex. Rosettes were manually isolated, dissociated into single cells and expanded in neural expansion medium. NPCs were then incubated for 48 hr in astrocytic CM. Cell proliferation was determined a using a modified BrdU labeling kit (Roche) as above.

Scratch Migration Assay {#S21}
-----------------------

As described elsewhere ([@R28]), NPCs were cultured to confluence in 60-mm dishes. The monolayer was scraped with a p200 pipet tip to create a "scratch." Debris was removed and astrocytic CM was added for 48 hr. Using phase contrast microscopy, images were acquired at 0, 24, and 48 hr after the scratch. The mean width of each scratch was calculated by averaging 6 width measurements taken at even intervals along the scratch length. The relative rate of migration was determined by calculating the percentage of scratch width invaded = 100% − (100% (mean width at t~x~ − mean width at t~0~). Quantification was carried out using ImageJ.

PQ Administration {#S22}
-----------------

p16-3MR mice were generated in the C57Bl6/J mouse strain as described previously ([@R19]). Animals were housed according to standard animal care protocols on a 12-hr light/dark cycle in a pathogen-free environment in the vivarium at the Buck Institute. 8-month-old male and female mice were injected intraperitoneally (i.p.) with saline or 7 mg/kg PQ (in saline) at 2-day intervals for a total of 6 doses. GCV (25 mg/kg body weight) was injected i.p. after the second PQ injection and every other day for a total of 5 doses. Animals were sacrificed 7 d after the last PQ administration as described previously ([@R38]). Animal care and use were in accordance with the National Institutes of Health guidelines for use of live animals and approved by the Animal Care and Use Committee at the Buck Institute.

qPCR of Mouse Striatal Tissues {#S23}
------------------------------

RNA from PQ- and saline-treated mice was reverse transcribed using an Applied Biosystems kit (Carlsbad CA). qRT-PCR reactions were performed using the following primers and probes:

1.  p16^INK4a^: FW, 5′-aatctccgcgaggaaagc-3′, RV, 5′-gtctgcagcggactccat-3′

2.  mRFP: FW, 5′--gacctcggcgtcgtagtg-3′, RV 5′--aagggcgagatcaagatgag-3′

3.  IL-6: FW, 5′-gctaccaaactggatataatcagga-3′, RV, 5′-ccaggtagctatggtac tccagaa-3′

4.  tubulin: FW, 5′-ctggaacccacggtcatc-3′ and RV, 5′-gtggccacgagcatagtt att-3′.

Immunofluorescence of Mouse Brain Tissue {#S24}
----------------------------------------

Whole brains were dissected and placed in cold 4% paraformaldehyde in PBS for 12 hr, washed in cold TBS, cut using a Leica VT 1000S Vibratome (collecting 50-μm horizontal sections in cryogenic buffer \[0.1 M potassium acetate, 40% ethylene glycol, and 1% polyvinyl pyrrolidone\]), and stored at −20°C. Free-floating sections containing the SN were transferred to 1 mL unmasking buffer (10 mM Tris and 1 mM EDTA \[pH 9\]) in 24-well dishes and microwaved 3 × 5 s at 100% power. Sections were washed in TBS, permeabilized in TBS plus 0.2% Triton X-100 for 1 hr, blocked in 5% normal goat serum in permeabilization buffer for 1 hr, and then bathed in blocking buffer at 4°C overnight with primary antibodies (chicken anti-TH with either rabbit anti-lamin B1 or rabbit anti-HMGB1, Abcam, ab18256, 1:200). Section were washed three times with TBS plus 0.1% Tween-20 for 1 hr and bathed in TBS, 0.1% Tween-20, 5% NGS, and fluorescent-conjugated antibodies (goat anti-rabbit immunoglobulin G \[IgG\]-Alexa 488 at 1:500; goat anti-chicken IgG/Alexa 633 at 1:500, and GFAP-cy3 at 1:2,000). Primary and secondary antibodies are the same as those listed for human IF. Sections were washed three times with TBS plus 0.1% Tween-20 for 2 hr before mounting on glass slides with ProLong Gold plus DAPI.

Analysis of Lamin B1 and HMGB1 in Mouse SNpc Astrocytes {#S25}
-------------------------------------------------------

Image acquisition and analysis of Lamin B1 and HMGB1 immunostaining in mouse astrocytes was conducted similar to that described for human brain tissues, except GFAP^+^ cells were chosen in fields containing TH staining. For HMGB1 analysis, the region of interest was drawn in the center of DAPI signal (in the nucleoplasm). Signals were calculated by averaging fluorescence from 5 astrocytes per section and subsequently averaging 3 sections per animal. Significance was calculated using non-paired t test with n = 4 animals in each condition.

Stereological SN TH^+^ Counts {#S26}
-----------------------------

Mouse tissues were fixed by perfusion as described and cryostat-cut sections (40 μm) were taken through the entire midbrain ([@R29]). TH^+^ neurons were immune-labeled by incubating the sections successively with a rabbit polyclonal anti-TH antibody (1:200) and biotinylated horse anti-rabbit IgG (1:200, Vector Laboratories) in combination with 3,3′-diaminobenzidine (DAB) reagents. Total \# TH^+^ SNpc neurons were counted from 4 to 5 litter-mates per group using the optical fractionator method ([@R38]).

Cylinder Test of Motor Behavior {#S27}
-------------------------------

Mice were placed individually in a cylinder to determine the number of rearing events over 1 min ([@R54]). Each rearing session was video recorded. The average number of rears over two trials was taken.

*In Vivo* BrdU Labeling and Quantitation {#S28}
----------------------------------------

BrdU (50 mg/kg; Sigma) in saline was given i.p. two times daily at 8-hr intervals on consecutive days (days 1--3 after PQ or saline administration). Mice were sacrificed on day 14 after the last injection. Brains were removed following 4% paraformaldehyde in PBS. Adjacent 50-μm sections were cut and stored at −80°C. BrdU detection was performed as described previously ([@R37]). Briefly, sections were incubated with 2 μg/mL mouse monoclonal anti-BrdU antibody (1:200, Roche) at 4°C overnight, washed with PBS, incubated with Alexa 488 anti-mouse secondary antibody (1:250) in blocking solution (Life Technologies) for 1 hr, and then washed and mounted on gelatin-coated slides with Fluoromount. SVZ BrdU^+^ cells were counted blinded in five 50-μm coronal sections per mouse spaced 200 μm apart under high power (200×) using a Nikon E300 microscope with a Magnifire digital camera. Results are expressed as the average number of BrdU^+^ cells per section.

Statistical Methods {#S29}
-------------------

For experiments using post-mortem human tissues ([Figure 1](#F1){ref-type="fig"}), n represents individuals; for all experiments using cultured cells ([Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}, and [5](#F5){ref-type="fig"}), n represents experimental replicates conducted on separate days; and for all mouse studies ([Figures 6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}), n represents individual mice. See figure legends for exact numbers for each individual experiment. All error bars in figures display SEM. Results were reported as significant when p values were \<0.05, running an unpaired Student's t test, unless noted otherwise in figure legends.
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![Senescence Markers in PD SNpc versus Age-Matched Controls\
(A) RNA isolated from autopsied SNpc tissues from PD versus controls (n = 5) were analyzed for p16^INK4a^ and SASP factor (IL-6, IL-1α, IL-8, and MMP-3) mRNA levels by qPCR. Transcripts were normalized to actin and are shown as fold change over control levels; \*p \< 0.05 and \*\*\*p \< 0.005.\
(B) Comparison of lamin B1 levels in PD versus age-matched control tissues. Representative immunofluorescence images (left side) showing lamin B1 protein levels (green) in GFAP^+^ (red) astrocytes (red arrows) in the PD SNpc (right panels) compared to age-matched controls (left panels). Neighboring GFAP^−^ cells (yellow arrows) retain lamin B1 expression in PD tissue. Quantification of the image data (right side) using mean pixel values (MPVs) showing that compared to controls (black bar; n = 5 individuals), PD tissues (gray bar; n = 5 individuals) contained significantly less Lamin B1 protein in GFAP^+^, but not GFAP^−^, cells; \*p \< 0.05 (paired t test).](nihms937937f1){#F1}

![PQ Induces Senescent Phenotypes in Cultured Human Astrocytes\
Cultured human astrocytes were treated with 100 or 250 μM PQ (or vehicle) for 24 hr, and senescence markers were evaluated 7 days later.\
(A) Representative images of BrdU labeling (left), and percentage of BrdU^+^ cells (right).\
(B) Representative images of SA-β-gal activity (left), and percentage of SA-β-gal^+^ cells (right).\
(C) qPCR of p16^INK4a^ mRNA levels.\
(D) Representative images of immunostaining for p16^INK4a^ (left), and percentage of p16^INK4a^-positive cells (right).\
(E) Representative images of 53BP1 immunostaining (left), and percentage of cells with \>1 53BP1 positive foci (right). Nuclei were counterstained with DAPI (blue) and white arrows denote enlarged cells shown in insets with punctate nuclear foci.\
(F) Secreted IL-6 levels measured by ELISA in conditioned media from non-senescent (vehicle) and senescent (PQ) astrocytes.\
For (A)--(D), n = 4, where n = experimental replicates; \*p \< 0.05, \*\*p \< 0.01, and \*\*\*p \< 0.005 (unpaired t test).](nihms937937f2){#F2}

![Paraquat Induces Morphological Features of Senescence and Arrests Proliferation in Both Fibroblasts and Astrocytes\
(A) Human fibroblasts (top panels) and human astrocytes (bottom panels) respond to PQ (1 mM and 300 μM, respectively) by decreasing the percentage of Ki67^+^ cells (green) compared to vehicle-treated controls. Representative images (left) and quantification (right) are shown. The decreased percentage of Ki67^+^ cells is similar to the decrease observed when cells are exposed to 10 Gy X-ray (IR, middle panels). For fibroblasts, both IR and 1 mM PQ significantly reduced Ki67 positivity; \*\*\*p \< 0.00001 (1 mM PQ was not significantly different from IR \[p \> 0.07\]; unpaired t test); n = 4 experiments. For astrocytes, IR and 300 μM PQ significantly reduced Ki67 positivity; \*\*p \< 0.01 (300 μM PQ was not significantly different from IR \[p \> 0.8\]; unpaired t test); n = 2 experiments.\
(B) Human fibroblasts (top) and human astrocytes (bottom) respond to PQ with a significant increase in nuclear size compared to vehicle-treated controls. Representative images (left) and quantification (right) are shown. Increased nuclear size is similar to the increase obtained with IR exposure. For fibroblasts both conditions (IR and 1mM PQ) are significantly greater than control; \*\*\*p \< 0.0001 (1 mM PQ is not significantly different from IR \[p \> 0.30\]; unpaired t test); n = 6 experiments. For astrocytes, both conditions (IR; 300 μM PQ) are significantly greater than control; \*p \< 0.02 (300 μM PQ is not significantly different from IR \[p \> 0.5\]; unpaired t test); n = 5 experiments.\
(C) Human fibroblasts respond to PQ (500 μM and 1 mM) with a significant loss of lamin B1 staining in the nuclear lamina relative to vehicle-treated controls. Representative images (left) and quantification (right) are shown. Decreased lamin B1 staining is similar to that obtained with IR. All conditions (IR; 500 μM and 1 mM PQ) are significantly different from control; \*\*p \< 0.01 (neither PQ condition differed significantly from IR \[p \> 0.25\]; unpaired t test); n = 2 experiments. (D) Human fibroblasts (1 mM PQ, top), astrocytes derived from iPSCs (40 μM PQ, middle), and murine primary astrocytes from p16-3MR neonates (40 μM PQ, bottom), display obvious increase in SA-β-gal activity, but cell death occurred when human and mouse astrocytes were exposed to higher concentrations of PQ (500 and 250 μM, respectively).](nihms937937f3){#F3}

![Lower Dosages of PQ Also Induce Cellular Senescence\
(A) Images and quantification percentage of SA-β-gal^+^ cells of human astrocytes exposed to 10 or 50 μM PQ for 48; also shown are results from exposure to 150 mM H~2~O~2~ for 2 hr and 50 nM MG132 for 48 hr; \*p \< 0.05, \*\*p \< 0.01, and \*\*\*p \< 0.005.\
(B) Images and quantification of cell density based on DAPI staining after exposure to 10 or 50 μM PQ for 48 hr; \*p \< 0.05 and \*\*p \< 0.01.\
For (A) and (B), n = 4, where n = experimental replicates (unpaired t test).](nihms937937f4){#F4}

![Factors Secreted by Senescent Human Astrocytes Have Detrimental Effects\
(A) Conditioned media (CM) from PQ-treated human astrocytes was added to DAergic neurons, and cell viability was assessed via an MTT assay; n = 3 experiments.\
(B) CM from PQ-treated human astrocytes was added to neural progenitor cells (NPCs), and proliferation of NPCs was assessed by BrdU positivity. Representative images (left) and quantification (right) are shown; n = 3 experiments.\
(C) NPCs migration in the presence of CM from vehicle-treated (black bars) versus PQ-treated (250 μM) (gray bars) astrocytes assayed using the scratch test; images show "cleared areas" of NPCs at 0 hr (far left panels), 24 hr (middle panels), and 48 hr (right panels) post-scratch. Black lines (perpendicular to scratches) indicate the width of the uninvaded area used for the quantification (right side). The percent scratch width \>24 and 48 hr was calculated; n = 5 scratches. The experiment was run twice with 2 different sets of CM (2 scratch assays). \*p \< 0.05 (unpaired t test).](nihms937937f5){#F5}

![PQ-Induced Senescence Is Prevented by Senescent Cell Ablation\
p16-3MR mice were treated with (1) saline, (2) PQ, (3) GCV alone, or (4) PQ plus GCV and assessed for senescence-associated markers.\
(A) Striatal RNA analyzed by qPCR for p16^INK4a^ and IL-6 mRNA levels.\
(B) SNpc immunofluorescence of Lamin B1 (green) of DAPI-stained nuclei (blue) within a field of TH^+^ (magenta)-stained neurites. GFAP^+^ (red) astrocytes are indicated by yellow arrows. A representative image from each of the 4 conditions (left) and corresponding quantification of nuclear Lamin B1 fluorescence (right). Top left inlays show lamin B1 staining within astrocytes.\
(C) HMGB1 immunofluorescence (green) counterstained as in (B); shown are representative images (left) and quantification of nuclear HMGB1 fluorescence (right).\
(D) Representative images (left) of lamin B1 immunofluorescence (green) in astrocytes versus non-astrocytic neighbors and quantification (right). Neighboring GFAP^−^ cells marked with yellow arrows.\
In all experiments, n = 4 mice for saline, PQ plus GCV, and GCV; and n = 3 mice for PQ. \*p \< 0.05 (unpaired t test).](nihms937937f6){#F6}

![Depletion of Senescent Cells Abrogates PQ-Mediated Neuropathological Phenotypes\
(A) Stereological SN TH^+^ cell counts were performed on p16-3MR mice treated with (1) saline, (2) PQ, (3) GCV alone, or (4) PQ plus GCV. Representative images (left) and quantification (right) are shown. Data are expressed as total SN TH^+^ cell numbers per animal; cell counts were verified by Nissl staining (not shown).\
(B) Neurogenesis assessed by quantitation of BrdU^+^ cells in the subventricular zone (SVZ) ([@R37]). Representative sections showing BrdU^+^ cells in the SVZ (left); quantitation of BrdU^+^ cells in the SVZ (right). Values are reported as BrdU^+^ cells per field averaged from 5 fields.\
(C) Prior to sacrifice, locomotor activity was monitored using the cylinder test as a measurement of spontaneous rearing rate. Still images demonstrating the behavioral phenotype (left) and quantification (right) are shown.\
For all experiments, n = 6 per condition; \*p \< 0.05 (unpaired t test).](nihms937937f7){#F7}

###### Highlights

-   Postmortem PD brain samples display increased astrocytic senescence

-   Cultured human astrocytes exposed to paraquat (PQ) become senescent

-   Clearance of senescent cells mitigates neurodegeneration in a mouse model of PD

-   Senescent Rastrocytes may contribute to the development of sporadic PD
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